Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6711)
All Articles published online
|
Publishing Process of This Article
|
Dec 28, 2014 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sasaki T, Isayama H, Nakai Y, Ito Y, Yasuda I, Toda N, Yagioka H, Matsubara S, Hanada K, Maguchi H, Kamada H, Hasebe O, Mukai T, Okabe Y, Maetani I, Koike K. Treatment outcomes of chemotherapy between unresectable and recurrent biliary tract cancer. World J Gastroenterol 2014; 20(48): 18452-18457 [PMID: 25561816 DOI: 10.3748/wjg.v20.i48.18452] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v20/i48/18452.htm |
| Number | Citing Articles |
| 1 |
Masato Yoshikawa, Tetsuya Ikemoto, Yuji Morine, Satoru Imura, Yu Saito, Shinichiro Yamada, Hiroki Teraoku, Atsushi Takata, Toshiaki Yoshimoto, Mitsuo Shimada. Aggressive resection of metachronous triple biliary cancer. The Journal of Medical Investigation 2017; 64(3.4): 299 doi: 10.2152/jmi.64.299
|
| 2 |
Naminatsu Takahara, Hiroyuki Isayama, Yousuke Nakai, Takashi Sasaki, Kazunaga Ishigaki, Kei Saito, Dai Akiyama, Rie Uchino, Suguru Mizuno, Hiroshi Yagioka, Hirofumi Kogure, Osamu Togawa, Saburo Matsubara, Yukiko Ito, Nobuo Toda, Minoru Tada, Kazuhiko Koike. Gemcitabine and S-1 versus gemcitabine and cisplatin treatment in patients with advanced biliary tract cancer: a multicenter retrospective study. Investigational New Drugs 2017; 35(3): 269 doi: 10.1007/s10637-017-0430-7
|
| 3 |
Shingo Seo, Takeshi Sudo, Masashi Inoue, Hirotaka Tashiro. Stage IVB Incidental Gallbladder Carcinoma with R0 Resection Achieved by Multidisciplinary Treatment Including Three Surgeries. The Japanese Journal of Gastroenterological Surgery 2019; 52(3): 166 doi: 10.5833/jjgs.2018.0077
|
| 4 |
Hao Li, Zhengyun Zhang, Zunqiang Zhou, Xianting Ding, Guangwen Zhou. Optimal combination of gemcitabine, sorafenib, and S-1 shows increased efficacy in treating cholangiocarcinoma in vitro and in vivo. Anti-Cancer Drugs 2016; 27(7): 600 doi: 10.1097/CAD.0000000000000365
|
| 5 |
Satoshi Kobayashi, Makoto Ueno, Kazuya Sugimori, Chigusa Morizane, Yasushi Kojima, Kuniyasu Irie, Yoshihiro Goda, Manabu Morimoto, Shinichi Ohkawa. Phase II study of fixed dose-rate gemcitabine plus S-1 as a second-line treatment for advanced biliary tract cancer. Cancer Chemotherapy and Pharmacology 2017; 80(6): 1189 doi: 10.1007/s00280-017-3461-z
|